BRAF and NRAS gene mutations occur at an early point in melanoma pathogenesis and are consistently sustained during further tumor progression, taking part in the pathogenesis of invasive melanoma but also in cooperation with other mutations 101. The gene discussed is BRAF; the disease is neoplasm.